Last reviewed · How we verify
regular dose of JiRui® Prunella oral liquid
regular dose of JiRui® Prunella oral liquid is a Small molecule drug developed by Xintian Pharmaceutical. It is currently FDA-approved.
At a glance
| Generic name | regular dose of JiRui® Prunella oral liquid |
|---|---|
| Sponsor | Xintian Pharmaceutical |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- regular dose of JiRui® Prunella oral liquid CI brief — competitive landscape report
- regular dose of JiRui® Prunella oral liquid updates RSS · CI watch RSS
- Xintian Pharmaceutical portfolio CI
Frequently asked questions about regular dose of JiRui® Prunella oral liquid
What is regular dose of JiRui® Prunella oral liquid?
regular dose of JiRui® Prunella oral liquid is a Small molecule drug developed by Xintian Pharmaceutical.
Who makes regular dose of JiRui® Prunella oral liquid?
regular dose of JiRui® Prunella oral liquid is developed and marketed by Xintian Pharmaceutical (see full Xintian Pharmaceutical pipeline at /company/xintian-pharmaceutical).
What development phase is regular dose of JiRui® Prunella oral liquid in?
regular dose of JiRui® Prunella oral liquid is FDA-approved (marketed).